Vimarsana
Biggest News Aggregation in the World

Early Feasibility Study News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Early Feasibility Study. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Early Feasibility Study Today - Breaking & Trending Today

ARYA Sciences Acquisition IV : ADAGIO MEDICAL Investor Presentation | June 2024 1 Form 8 K - Vimarsana News

ARYA Sciences Acquisition IV : ADAGIO MEDICAL Investor Presentation | June 2024 1 Form 8 K

ADAGIO MEDICAL Investor Presentation | June 2024 1 DISCLAIMER This investor presentation is for informational purposes only to assist interested parties in making their...

CARMAT Continues to Build on Its Momentum in the EFICAS Study and Reiterates Confidence in Its 2024 Outlook - Vimarsana News

CARMAT Continues to Build on Its Momentum in the EFICAS Study and Reiterates Confidence in Its 2024 Outlook

EFICAS study reaches the milestone of 20 implants Interim study results above expectations Confirmation of short-term financial support from several key shareholders ...

Raydiant Oximetry Secures FDA Approval for Lumerah Investigational Device Exemption (IDE) Study - Vimarsana News

Raydiant Oximetry Secures FDA Approval for Lumerah Investigational Device Exemption (IDE) Study

SAN RAMON, Calif., April 10, 2024 (GLOBE NEWSWIRE) -- Raydiant Oximetry, Inc., a clinical-stage medical device company that develops medical tec...

Biosense Webster Begins Enrollment of Pivotal Trial Evaluating the Laminar Left Atrial Appendage Elimination Device - Vimarsana News

Biosense Webster Begins Enrollment of Pivotal Trial Evaluating the Laminar Left Atrial Appendage Elimination Device

Investigational device designed for Left Atrial Appendage Elimination (LAAX) to reduce the risk of stroke in patients with non-valvular atrial fibrillation 

Aria CV Announces First Patient Successfully Implanted with Second-Generation Pulmonary Hypertension System - Vimarsana News

Aria CV Announces First Patient Successfully Implanted with Second-Generation Pulmonary Hypertension System

Gen 2 System has potential to reduce cardiac workload and enhance blood flow